Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.
about
Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson's Disease?Ryanodine Receptors in Autophagy: Implications for Neurodegenerative Diseases?Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function.Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.Quantitative Proteomic Analysis Reveals That Arctigenin Alleviates Concanavalin A-Induced Hepatitis Through Suppressing Immune System and Regulating AutophagyModulation of Mitochondrial Dynamics in Neurodegenerative Diseases: An Insight Into Prion Diseases
P2860
Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.
@en
Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.
@nl
type
label
Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.
@en
Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.
@nl
prefLabel
Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.
@en
Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.
@nl
P2093
P2860
P356
P1476
Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.
@en
P2093
Dongdong Wang
Huaishan Wang
Jianmin Zhang
P2860
P356
10.3389/FNEUR.2017.00527
P577
2017-10-04T00:00:00Z